T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CINC
701
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $41.9M | 0.01% |
1,277,379
+597,757
| +88% | +$16.9M |
|
702
Agios Pharmaceuticals
AGIO
$2B
| $41.8M | 0.01% |
1,476,473
-1,070,513
| -42% | -$28.7M |
|
703
Crocs
CROX
$6.36B
| $41.6M | 0.01% |
606,099
+2,239
| +0.4% | +$155K |
|
704
Invesco
IVZ
$14.3B
| $41.6M | 0.01% |
3,035,742
+95,267
| +3% | +$1.61M |
|
705
Dow Inc
DOW
$21.9B
| $41.6M | 0.01% |
946,220
+4,025
| +0.4% | +$204K |
|
706
Vail Resorts
MTN
$5.18B
| $41.6M | 0.01% |
192,751
-2,217,817
| -92% | -$504M |
|
|
AIRC
707
DELISTED
Apartment Income REIT Corp.
AIRC
| $41.4M | 0.01% |
1,072,904
-9,567
| -0.9% | -$405K |
|
708
Parker-Hannifin
PH
$134B
| $41.2M | 0.01% |
170,055
-63,692
| -27% | -$17.2M |
|
709
Littelfuse
LFUS
$11.4B
| $41.1M | 0.01% |
207,040
-1,623,305
| -89% | -$388M |
|
710
M&T Bank
MTB
$36.6B
| $41.1M | 0.01% |
233,284
-4,309
| -2% | -$763K |
|
711
Coca-Cola Consolidated
COKE
$12.7B
| $41M | 0.01% |
995,140
-2,908,720
| -75% | -$143M |
|
|
XM
712
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $40.9M | 0.01% |
4,017,257
+659,204
| +20% | +$8.19M |
|
713
ICU Medical
ICUI
$4.58B
| $40.8M | 0.01% |
271,197
-2,437,918
| -90% | -$406M |
|
714
VICI Properties
VICI
$29B
| $40.8M | 0.01% |
1,365,980
+22,319
| +2% | +$737K |
|
715
Louisiana-Pacific
LPX
$5.18B
| $40.8M | 0.01% |
796,238
-2,029
| -0.3% | -$115K |
|
716
Northern Trust
NTRS
$34.8B
| $39.7M | 0.01% |
463,723
-2,987,036
| -87% | -$288M |
|
|
ANSS
717
DELISTED
Ansys
ANSS
| $39.6M | 0.01% |
178,547
+1,089
| +0.6% | +$278K |
|
|
IAA
718
DELISTED
IAA, Inc. Common Stock
IAA
| $39.6M | 0.01% |
1,242,503
-52,649
| -4% | -$1.87M |
|
719
Hexcel
HXL
$7.74B
| $39.6M | 0.01% |
764,928
+3,580
| +0.5% | +$208K |
|
720
Diamondback Energy
FANG
$55.9B
| $39.4M | 0.01% |
327,001
-1,735,341
| -84% | -$217M |
|
|
GBIO
721
DELISTED
Generation Bio
GBIO
| $39.3M | 0.01% |
739,557
-153,604
| -17% | -$9.61M |
|
722
Consolidated Edison
ED
$40.1B
| $39.2M | 0.01% |
456,640
+5,283
| +1% | +$510K |
|
723
First Industrial Realty Trust
FR
$8.4B
| $39M | 0.01% |
870,027
-1,281,762
| -60% | -$64.9M |
|
724
CorVel
CRVL
$3.25B
| $39M | 0.01% |
844,638
+861
| +0.1% | +$44.7K |
|
|
AZPN
725
DELISTED
Aspen Technology Inc
AZPN
| $38.9M | 0.01% |
163,338
-892
| -0.5% | -$186K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.